Identification of residues critical to the activity of human granulocyte colony-stimulating factor

被引:45
|
作者
ReidhaarOlson, JF
DeSouzaHart, JA
Selick, HE
机构
[1] Affymax Research Institute, Santa Clara, CA 95051
关键词
D O I
10.1021/bi952705x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alanine scanning mutagenesis of human granulocyte colony-stimulating factor (G-CSF) was used to identify residues critical for the cell-proliferative activity of the protein. Fifty-eight residues, most of them on the protein surface, were independently mutated to alanine. Most of the variants retained full biological activity; however, 15 mutants were significantly impaired in their ability to stimulate bone marrow cell proliferation in vitro. Four of these variants contain mutations at buried residues and two have substitutions at side chains involved in intramolecular hydrogen bonds. The remaining nine down mutations identify two regions on the surface of the molecule important for biological activity. Consistent with these observations, measurements of binding to NFS-60 cells indicate that the residues most important for receptor binding are Lys40 and Phe144 in site 1 and Glu19 in site 2. In addition to these residues, Val48 and Leu49 in site 1 and Leu15, Asp112, and Leu124 in site 2 are also important for biological activity. These results suggest the presence of two binding sites on the cytokine surface required for dimerization of the G-CSF receptor.
引用
收藏
页码:9034 / 9041
页数:8
相关论文
共 50 条
  • [1] CHEMOTACTIC ACTIVITY OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR
    WANG, JM
    CHEN, ZG
    COLELLA, S
    BONILLA, MA
    WELTE, K
    MANTOVANI, A
    BORDIGNON, C
    BLOOD, 1988, 72 (05) : 1456 - 1460
  • [2] STRUCTURE-FUNCTION STUDIES OF HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR - IDENTIFICATION OF RESIDUES REQUIRED FOR ACTIVITY
    CLARKLEWIS, I
    LOPEZ, AF
    TO, LB
    VADAS, MA
    SCHRADER, JW
    HOOD, LE
    KENT, SBH
    JOURNAL OF IMMUNOLOGY, 1988, 141 (03): : 881 - 889
  • [3] CLINICAL-EXPERIENCE WITH RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR AND GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR
    MORSTYN, G
    LIESCHKE, GJ
    SHERIDAN, W
    LAYTON, J
    CEBON, J
    FOX, RM
    SEMINARS IN HEMATOLOGY, 1989, 26 (02) : 9 - 13
  • [4] Pharmacoeconomics of Granulocyte Colony-Stimulating Factor: A Critical Review
    Barnes, Gisoo
    Pathak, Ashutosh
    Schwartzberg, Lee
    ADVANCES IN THERAPY, 2014, 31 (07) : 683 - 695
  • [5] Pharmacoeconomics of Granulocyte Colony-Stimulating Factor: A Critical Review
    Gisoo Barnes
    Ashutosh Pathak
    Lee Schwartzberg
    Advances in Therapy, 2014, 31 : 683 - 695
  • [6] GRANULOCYTE COLONY-STIMULATING FACTOR
    TABBARA, IA
    SOUTHERN MEDICAL JOURNAL, 1993, 86 (03) : 350 - 355
  • [7] GRANULOCYTE COLONY-STIMULATING FACTOR
    不详
    CANCER INVESTIGATION, 1989, 7 (05) : 525 - 525
  • [8] Granulocyte colony-stimulating factor
    Harriss, Julian P.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2006, 175 (09) : 1095 - 1095
  • [9] Efficacy of recombinant human granulocyte colony-stimulating factor and recombinant human granulocyte macrophage colony-stimulating factor in neutropenic children with malignancies
    Lydaki, E
    Bolonaki, E
    Stiakaki, E
    Dimitriou, H
    Kambourakis, A
    Kalmantis, T
    Kalmanti, M
    BLOOD, 1995, 86 (10) : 2785 - 2785
  • [10] IDENTIFICATION OF CRITICAL AMINO-ACID-RESIDUES IN HUMAN AND MOUSE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND THEIR INVOLVEMENT IN SPECIES SPECIFICITY
    SHANAFELT, AB
    JOHNSON, KE
    KASTELEIN, RA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (21) : 13804 - 13810